BioCorRx Inc. (BICX) financial statements (2020 and earlier)

Company profile

Business Address 2390 EAST ORANGEWOOD AVENUE
ANAHEIM, CA 92806
State of Incorp.
Fiscal Year End December 31
SIC 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3000000
Cash and cash equivalents3000000
Restricted cash and investments  0    
Receivables      0
Prepaid expense0000000
Other current assets     44
Other undisclosed current assets000 0(4)(4)
Total current assets:3000001
Noncurrent Assets
Operating lease, right-of-use asset0✕✕✕✕✕✕
Property, plant and equipment0000000
Long-term investments and receivables, including:0000000
Long-term investments0000000
Other undisclosed long-term investments and receivables      0
Intangible assets, net (including goodwill)000  4✕
Intangible assets, net (excluding goodwill)000  4 
Prepaid expense    00 
Other undisclosed noncurrent assets00 01 4
Total noncurrent assets:1000144
TOTAL ASSETS:4100144
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2211111
Accounts payable111    
Accrued liabilities  000  
Interest and dividends payable110    
Settlement liabilities  00  ✕
Other undisclosed accounts payable and accrued liabilities00(0)1111
Deferred revenue0✕✕✕✕✕✕
Debt(0)1 010 
Derivative instruments and hedges, liabilities   00  
Due to related parties00000  
Deferred revenue and credits✕✕00110
Other undisclosed current liabilities0400000
Total current liabilities:3622421
Noncurrent Liabilities
Long-term debt and lease obligation0    01
Long-term debt, excluding current maturities     01
Operating lease, liability0✕✕✕✕✕✕
Liabilities, other than long-term debt, including:0036123
Deferred revenue and credits✕✕01111
Deferred revenue0✕✕✕✕✕✕
Derivative instruments and hedges, liabilities   50  
Other undisclosed liabilities, other than long-term debt 021012
Other undisclosed noncurrent liabilities2    (0)(1)
Total noncurrent liabilities:2036123
Total liabilities:5649544
Stockholders' equity
Stockholders' equity attributable to parent, including:(1)(6)(4)(8)(3)00
Preferred stock 00000 
Common stock0000000
Common stock, value, subscriptions00000 ✕
Additional paid in capital604945111095
Accumulated deficit(61)(55)(49)(19)(13)(9)(5)
Other undisclosed stockholders' equity attributable to parent(0)(0)00 00
Stockholders' equity attributable to noncontrolling interest(0)      
Other undisclosed stockholders' equity00     
Total stockholders' equity:(1)(6)(4)(8)(3)00
Other undisclosed liabilities and equity(0)(0)     
TOTAL LIABILITIES AND EQUITY:4100144

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0011111
Revenue, net✕✕11111
Cost of revenue(0)(0)(0)(0)(0)(0)(0)
Cost of goods and services sold   (3)  (0)
Gross profit:0001111
Operating expenses(6)(5)(4)(3)(6)(4)(3)
Other undisclosed operating income00000  
Operating loss:(6)(5)(3)(2)(5)(3)(3)
Nonoperating income (expense)(0)(2)(27)(4)0  
Interest and debt expense(0)00(0)1(0)0
Loss from continuing operations before income taxes:(6)(7)(29)(6)(4)(4)(2)
Income tax expense      (0)
Net loss:(6)(7)(29)(6)(4)(4)(2)
Net income attributable to noncontrolling interest67     
Other undisclosed net income (loss) attributable to parent(6)(7)(0)0(1) (1)
Net loss available to common stockholders, diluted:(6)(7)(30)(6)(5)(4)(4)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(6)(7)(29)(6)(4)(4)(2)
Comprehensive loss:(6)(7)(29)(6)(4)(4)(2)
Comprehensive income, net of tax, attributable to noncontrolling interest67     
Comprehensive loss, net of tax, attributable to parent:(0)(0)(29)(6)(4)(4)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: